Cannabis: Medical Treatments

Department of Health and Social Care written question – answered on 13th May 2019.

Alert me about debates like this

Photo of Jo Stevens Jo Stevens Labour, Cardiff Central

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 April 2019 to Question 244142 on Cannabis: Medical Treatments, whether his Department is aware of any instances of (a) CBD and (b) THC being prescribed by the NHS since 1 January 2019.

Photo of Seema Kennedy Seema Kennedy The Parliamentary Under-Secretary for Health and Social Care

The published data shows that the following number of items of Nabilone (a synthetic product which mimics tetrahydrocannabinol (THC)) and Sativex (a product containing natural THC and cannabidiol (CBD)) were dispensed in January and February 2019.

Number of prescription items

January 2019

February 2019

Nabilone

44

36

Sativex

167

159

Data, from the NHS Business Services Authority for January and February 2019, suggest that three National Health Service prescriptions were dispensed for unlicensed cannabis-based products for medicinal use in primary care in England during this time. Additionally, the NHS Business Services Authority data report that 10 private prescriptions were dispensed for unlicensed cannabis-based products for medicinal use in January and February 2019.

Unlike NHS primary care where all dispensed prescriptions are processed centrally, this is not the case for secondary care. This information is collected by a third party and not routinely published.

Does this answer the above question?

Yes2 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.